Indeed, IL-7/IL-7R-mediated signaling plays an oncogenic role in hematological tumors by may being resistant to conventional chemotherapy and targeted therapeutics [11,12]. This evidence concerns the gene IL7 and hematopoietic and lymphoid cell neoplasm.